Standard Biotools (LAB) Divestments (2020 - 2026)
Standard Biotools (LAB) reported Divestments of $363.2 million for Q1 2026, up 18061.1% on a QoQ basis from $2.0 million in Q3 2021.
Standard Biotools (LAB) has 3 years of Divestments data on file, last reported at $363.2 million in Q1 2026.
- Quarterly Divestments changed N/A year-over-year to $363.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $363.2 million (changed N/A YoY) and the FY2021 annual result came in at $1.3 million, down 93.73% from the prior year.
- Divestments rose to $363.2 million in Q1 2026 per LAB's latest filing, from $2.0 million in the prior quarter.
- Across five years, Divestments topped out at $363.2 million in Q1 2026 and bottomed at $363.2 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn | 363.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 363.22 Mn |
| Sep 30, 2021 | 2.00 Mn |
| Jun 30, 2021 | 2.00 Mn |
| Mar 31, 2021 | 2.00 Mn |
| Dec 31, 2020 | 9.89 Mn |
| Sep 30, 2020 | 11.15 Mn |